October 2nd 2024
Findings from two Baltimore medical centers presented at the American Society for Radiation Oncology Annual Meeting suggest spiritual themes and distrust may be behind the decline in trial participation.
September 30th 2024
September 25th 2024
September 11th 2024
Leveraging Technology to Bridge Clinical Trial Processes and Real-World Health Care
March 22nd 2018Building upon the usage of technology in health care delivery, integrating technology into clinical research as a care option will be a game changer in achieving greater participation in clinical research and decreasing the overall time for trial completion.
Data Shows Pharma is not Fully Incorporating Patient Endpoints in Study Design
July 5th 2017In this article, we will analyze themes from asthma patient conversations via HealthUnlocked, an online healthcare social network, and compare these themes to asthma clinical trial endpoints from large pharma studies.
Getting the "Right" Patient Input to Decision-Making
November 1st 2016Rising patient engagement in drug development has been welcomed when it comes to discussions of policy. In Europe, a new initiative has emerged that aims to improve this theme by finding the right balance into patient links with decision-making on medicines.
FDA & Industry Share Perspectives on Patient Centricity
October 28th 2016As patient centricity continues to evolve, the differences in perspective between sponsors and the FDA over how to define this concept run parallel. With rising awareness will come the need for a definitive model that incorporates patient centricity in drug development.
Why CRCO is the Key to Increasing Patient-Centricity
September 19th 2016The clinical trials space has shifted to a patient friendly, fast and easy process thanks to technological improvements, despite some gaps in the existing model. A Clinical Research Care Option (CRCO) can fill these gaps by fostering a more inclusive clinical research environment.